Patents Assigned to Opti Medical Systems
  • Patent number: 9360474
    Abstract: The invention relates to devices comprising a sensor layer capable of binding magnesium ions and a scavenging layer that preferentially binds to calcium ions in the presence of both magnesium ions and calcium ions. The sensor layers can comprise known or novel luminionophores. The invention further relates to methods of selectively detecting magnesium ion concentration in the presence of calcium ions.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: June 7, 2016
    Assignee: OPTI Medical Systems, Inc.
    Inventors: Peter Chaoquan Zhu, Yingzi Wu
  • Patent number: 9018377
    Abstract: The invention provides compounds of formula I F-L-Q (I) where F comprises a fluorophore capable of absorbing energy at an excitation wavelength and, in the absence of a quencher, emitting energy at an emission wavelength, which is different than the excitation wavelength; Q comprises a quencher; L comprises a linker moiety having two ends, one end being covalently bound to F and the other end being covalently bound to Q. The compounds are capable of undergoing a reversible reaction (1), provided below: (1) where Q+ is an oxidized form of Q representing the absence of a quencher, Ox comprises an oxidizing agent, which is capable of oxidizing Q to its oxidized form Q, and Red comprises a reducing agent, which is capable of converting Q back to its reduced form Q. The compounds can undergo photo-induced electron transfer when irradiated with energy and when Q exists in its oxidized form, Q+.
    Type: Grant
    Filed: July 22, 2010
    Date of Patent: April 28, 2015
    Assignee: OPTI Medical Systems
    Inventors: Huarui He, Chao Lin
  • Publication number: 20120183984
    Abstract: The invention provides compounds of formula I F-L-Q (I) where F comprises a fluorophore capable of absorbing energy at an excitation wavelength and, in the absence of a quencher, emitting energy at an emission wavelength, which is different than the excitation wavelength; Q comprises a quencher; L comprises a linker moiety having two ends, one end being covalently bound to F and the other end being covalently bound to Q. The compounds are capable of undergoing a reversible reaction (1), provided below: (1) where Q+ is an oxidized form of Q representing the absence of a quencher, Ox comprises an oxidizing agent, which is capable of oxidizing Q to its oxidized form Q, and Red comprises a reducing agent, which is capable of converting Q back to its reduced form Q. The compounds can undergo photo-induced electron transfer when irradiated with energy and when Q exists in its oxidized form, Q+.
    Type: Application
    Filed: July 22, 2010
    Publication date: July 19, 2012
    Applicant: OPTI MEDICAL SYSTEMS
    Inventors: Huarui He, Chao Lin
  • Patent number: 8158259
    Abstract: The invention is directed to optical sensors for measuring clinically relevant analytes, their methods of manufacture, and their various uses. In an effort to develop a dry calibration method for the optical sensors of the invention it is discovered that water content inside or in the immediate vicinity of a such a sensor can have a major impact on fluorescence intensity (i.e., a sensor's response in the dry state). Thus, one of the objectives of the invention is the elimination of the bias of sensor responses measured at different humidity environments.
    Type: Grant
    Filed: December 6, 2007
    Date of Patent: April 17, 2012
    Assignee: Opti Medical Systems
    Inventors: Narayanan Ramamurthy, Huarui He, Chao Lin
  • Patent number: 7960181
    Abstract: The invention relates to methods of determining potassium ions in a sample, wherein the ions are contacted with a compound having chromophoric moiety and an ionophoric moiety, where the ionophoric moiety interacts with the potassium ions present in the sample, resulting in the chromophoric moiety changing its radiation absorption properties in the ultraviolet and visible regions of the spectrum. For example, a change in an intensity of an absorption maximum is measured and the ion concentration is determined accordingly.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: June 14, 2011
    Assignee: OPTI Medical Systems
    Inventors: Huarui He, Chao Lin, Neeta Raje, Chuseng Liu
  • Patent number: 7858383
    Abstract: The invention relates to methods of determining sodium ions in a sample, wherein the ions are contacted with a compound having chromophoric moiety and an ionophoric moiety, where the ionophoric moiety interacts with the sodium ions present in the sample, resulting in the chromophoric moiety changing its radiation absorption properties in the ultraviolet and visible regions of the spectrum. For example, a change in an intensity of an absorption maximum is measured and the ion concentration is determined accordingly.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: December 28, 2010
    Assignee: Opti Medical Systems
    Inventors: Huarui He, Chao Lin, Neeta Raje, Chusheng Liu